HENDERSON, NV--(Marketwired - May 20, 2015) - Rx Safes, Inc. (OTC PINK: RXSF), the developer of patented fingerprint healthcare security products and secure prescription medicine lock-boxes, previously announced that it had engaged the services of a Grant Writer to assist in identifying and obtaining private, local, state and federal government grant funds to purchase units of its revolutionary flagship product, the Rx DrugSAFE. Demonstrating its commitment to successfully implement this program, the Company announced today that it has executed an MOU with Advocare Solutions, Inc., a Florida based organization dedicated to helping families prevent and treat drug and alcohol addiction, for the purchase of 10,000 units of the Company's Rx DrugSAFE product, at a purchase price of $1,000,000.

The funds for the purchase of the Rx DrugSAFE units are expected to come from a Grant that is being funded by the Broward County Human Services Department, Community Partnerships Division, to address substance abuse issues within the County. Rx Safes has prepared and will be submitting the grant proposal on behalf of Advocare on May 22nd, the award will be made August 22nd with funds available for disbursement on October 1, 2015. 

There are many local stakeholders expected to participate in this initiative including the Broward County Sheriff's Department. Advocare intends to provide the Rx DrugSAFE units to at-risk families throughout Broward County, in partnership with the Sheriff's Department, which is expected to host various Prescription Drug Awareness events throughout the year. The exact details of this collaboration will be announced once the Grant funds have been awarded. 

"The Broward County initiative is an important first step in proving the effectiveness of our new grant writing program and will open the door for a national roll-out, allowing us to offer this service to countless community based organizations across the US. This program makes it easy and affordable for these organizations to obtain and distribute the Rx DrugSAFE product to at risk families and offers a real first line of defense in the safe and secure storage of prescription medications to help prevent incidents of abuse and accidental poisonings," stated Mrs. Lorraine Yarde, Rx Safes, Inc.'s CEO.

This is just the first of many grants the Company has identified that are available for funding community based drug addiction awareness and prevention initiatives and we hope to file a minimum of 4 grant applications a quarter under this program alone.

Prescription drug abuse has reached epidemic proportions and the Company has begun to integrate its patented fingerprint technology into other security solutions which will further address the drug diversion issue facing both consumers and professional healthcare facilities across the USA. The company is also working on a nationwide retail plan to make the Rx DrugSAFE available to consumers through a program with a major retail pharmacy, details of which will be announced in the coming months.

About Rx Safes, Inc.

Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxdrugsafe.com.

Forward-Looking Statements for RXSF:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Like us on Facebook at https://www.facebook.com/rx.drugsafe
Follow us on Twitter at https://twitter.com/RxDrugSAFE

Contact Information:

Investor Relations Contact:

Email: IR@RxSafes.com
Telephone: 1-844-RXSAFES Ext 4